S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

VTVT vTv Therapeutics Inc

27.96

0.06 (0.22%)

After Hours

Last Updated: 15:30:00

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more vTv Therapeutics Charts.

vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more vTv Therapeutics Charts.

Vtv Therapeutics Inc. News

CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
Tuesday 19 March 2024 (1 month ago) • PR Newswire (US)

vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Wednesday 13 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D - General statement of acquisition of beneficial ownership
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
Monday 4 March 2024 (2 months ago) • GlobeNewswire Inc.

vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE
Thursday 22 February 2024 (2 months ago) • PR Newswire (US)

More Vtv Therapeutics Inc. News Articles

Global Developments (PK)

NaturalShrimp (QB)

Mullen Automotive

FBEC Worldwide (PK)

Wanderport (PK)

NioCorp Developments

Fannie Mae (QB)

Branded Legacy (PK)

International Star (PK)

Virexit Technologies (PK)

Tonner One World (PK)

Impact Fusion (PK)

TideRock Companies (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions